Whither Peer Review at CIHR

Matthew Herder reviews three significant problems with the peer review system at CIHR, as a result of which high-quality research by social science and humanities researchers is left ‘undone.’

Talking Plasma and Markets with my Mother

Matthew Herder shares a conversation with his mother about why she is a regular plasma donor.

Beware ‘Innovation-Speak’

Matthew Herder wrote a Master’s thesis on Canadian science policy some ten years ago and by the time he was done, he had sworn off the word ‘innovation.’

Enacting Pharmaceutical Transparency – Who, What, How, When, & Why

Matthew Herder shares a template letter that physicians, researchers, civil society groups, investigative journalists, and others can use to gain access to unpublished pharmaceutical safety and effectiveness data.

Testing Canada’s New Pharmaceutical Transparency Law

Matthew Herder and Trudo Lemmens explore the ways that Canada’s transparency legislation may limit researchers’ abilities to scrutinize drug safety and effectiveness.